Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy

References

• Narmani A, Jafari SM. Chitosan-based nanodelivery systems for cancer therapy: recent advances. Carbohydr Polym. 2021;272:118464. doi: 10.1016/j.carbpol.2021.118464
   PubMed Web of Science ®Google Scholar
• Yousefi M, Narmani A, Jafari SM. Dendrimers as efficient nanocarriers for the protection and delivery of bioactive phytochemicals. Adv Colloid Interface Sci. 2020;278:102125. doi: 10.1016/j.cis.2020.102125
   PubMed Web of Science ®Google Scholar
• Ion D, Niculescu A-G, Păduraru DN, et al. An up-to-date review of natural nanoparticles for cancer management. Pharmaceutics. 2021;14(1):18. doi: 10.3390/pharmaceutics14010018
   PubMed Web of Science ®Google Scholar
• Naderlou E, Salouti M, Amini B, et al. Enhanced sensitivity and efficiency of detection of Staphylococcus aureus based on modified magnetic nanoparticles by photometric systems. Artific Cells Nanomed Biotechnol. 2020;48(1):810–817. doi: 10.1080/21691401.2020.1748638
   PubMed Web of Science ®Google Scholar
• Akhlaq M, Azad AK, Ullah I, et al. Methotrexate-loaded gelatin and polyvinyl alcohol (Gel/PVA) hydrogel as a Ph-sensitive matrix. Polymers. 2021;13(14):2300. doi: 10.3390/polym13142300
   PubMed Web of Science ®Google Scholar
• Narmani A, Farhood B, Haghi-Aminjan H, et al. Gadolinium nanoparticles as diagnostic and therapeutic agents: their delivery systems in magnetic resonance imaging and neutron capture therapy. J Drug Delivery Sci Technol. 2018;44:457–466. doi: 10.1016/j.jddst.2018.01.011
   Web of Science ®Google Scholar
• Narmani A, Yavari K, Mohammadnejad J. Imaging, biodistribution and in vitro study of smart 99mTc-PAMAM G4 dendrimer as novel nano-complex. Colloids Surf B Biointerfaces. 2017;159:232–240. doi: 10.1016/j.colsurfb.2017.07.089
   PubMed Web of Science ®Google Scholar
• Jia X, Zhang B, Chen C, et al. Immobilization of chitosan grafted carboxylic Zr-MOF to porous starch for sulfanilamide adsorption. Carbohydr Polym. 2021;253:117305. doi: 10.1016/j.carbpol.2020.117305
   PubMed Web of Science ®Google Scholar
• Khalaf EM, Abood NA, Atta RZ, et al. Recent progressions in biomedical and pharmaceutical applications of chitosan nanoparticles: a comprehensive review. Int j biol macromol. 2023;231:123354. doi: 10.1016/j.ijbiomac.2023.123354
   PubMed Web of Science ®Google Scholar
• Narmani A, Kamali M, Amini B, et al. Highly sensitive and accurate detection of Vibrio cholera O1 OmpW gene by fluorescence DNA biosensor based on gold and magnetic nanoparticles. Process Biochem. 2018;65:46–54. doi: 10.1016/j.procbio.2017.10.009
   Web of Science ®Google Scholar
• Mortezaee K, Narmani A, Salehi M, et al. Synergic effects of nanoparticles-mediated hyperthermia in radiotherapy/chemotherapy of cancer. Life Sci. 2021;269:119020. doi: 10.1016/j.lfs.2021.119020
   PubMed Web of Science ®Google Scholar
• Narmani A, Arani MAA, Mohammadnejad J, et al. Breast tumor targeting with PAMAM-PEG-5FU-99mTc as a new therapeutic nanocomplex: in in-vitro and in-vivo studies. Biomed Microdevices. 2020;22(2):1–13. doi: 10.1007/s10544-020-00485-5
   Web of Science ®Google Scholar
• Zhuang J, Kuo C-H, Chou L-Y, et al. Optimized metal–organic-framework nanospheres for drug delivery: evaluation of small-molecule encapsulation. ACS Nano. 2014;8(3):2812–2819. doi: 10.1021/nn406590q
   PubMed Web of Science ®Google Scholar
• Zhong H, Chan G, Hu Y, et al. A comprehensive map of FDA-approved pharmaceutical products. Pharmaceutics. 2018;10(4):263. DOI:10.3390/pharmaceutics10040263
   PubMed Web of Science ®Google Scholar
• Ghitman J, Biru EI, Stan R, et al. Review of hybrid PLGA nanoparticles: future of smart drug delivery and theranostics medicine. Mater Design. 2020;193:108805. doi: 10.1016/j.matdes.2020.108805
   Web of Science ®Google Scholar
• Zhao X, Liu Y, Yu Y, et al. Hierarchically porous composite microparticles from microfluidics for controllable drug delivery. Nanoscale. 2018;10(26):12595–12604. doi: 10.1039/C8NR03728K
   PubMed Web of Science ®Google Scholar
• Pandita D, Kumar S, Lather V. Hybrid poly (lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.Drug discovery today 2015;20(1):95–104.
   PubMed Web of Science ®Google Scholar
• Harguindey A, Domaille DW, Fairbanks BD, et al. Synthesis and assembly of click‐nucleic‐acid‐containing PEG–PLGA nanoparticles for DNA delivery. Adv Mater. 2017;29(24):1700743. doi: 10.1002/adma.201700743
   Web of Science ®Google Scholar
• Zhou S, Huang Y, Chen Y, et al. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy. Biomaterials. 2020;235:119795. doi: 10.1016/j.biomaterials.2020.119795
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. JControlled Release. 2012;161(2):505–522. doi: 10.1016/j.jconrel.2012.01.043
   PubMed Web of Science ®Google Scholar
• Operti MC, Bernhardt A, Grimm S, et al. PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up. Int J Pharmaceut. 2021;605:120807.
   PubMed Web of Science ®Google Scholar
• Cano A, Sánchez-López E, Ettcheto M, et al. Current advances in the development of novel polymeric nanoparticles for the treatment of neurodegenerative diseases. Nanomedicine. 2020;15(12):1239–1261. doi: 10.2217/nnm-2019-0443
   PubMed Web of Science ®Google Scholar
• Swider E, Koshkina O, Tel J, et al. Customizing poly (lactic-co-glycolic acid) particles for biomedical applications. Acta Biomaterialia. 2018;73:38–51. doi: 10.1016/j.actbio.2018.04.006
   PubMed Web of Science ®Google Scholar
• Andhariya JV, Jog R, Shen J, et al. In vitro-in vivo correlation of parenteral PLGA microspheres: effect of variable burst release. JControlled Release. 2019;314:25–37. doi: 10.1016/j.jconrel.2019.10.014
   PubMed Web of Science ®Google Scholar
• Fonte P, Araújo F, Silva C, et al. Polymer-based nanoparticles for oral insulin delivery: revisited approaches. Biotechnol Adv. 2015;33(6):1342–1354. doi: 10.1016/j.biotechadv.2015.02.010
   PubMed Web of Science ®Google Scholar
• Gentile P, Chiono V, Carmagnola I, et al. An overview of poly (lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci. 2014;15(3):3640–3659. doi: 10.3390/ijms15033640
   PubMed Web of Science ®Google Scholar
• Angkawinitwong U, Courtenay AJ, Rodgers AM, et al. A novel transdermal protein delivery strategy via electrohydrodynamic coating of PLGA microparticles onto microneedles. ACS Appl Mater Inter. 2020;12(11):12478–12488. doi: 10.1021/acsami.9b22425
   PubMed Web of Science ®Google Scholar
• Battisti M, Vecchione R, Casale C, et al. Non-invasive production of multi-compartmental biodegradable polymer microneedles for controlled intradermal drug release of labile molecules. Front Bioeng Biotechnol. 2019;7:296. doi: 10.3389/fbioe.2019.00296
   PubMed Web of Science ®Google Scholar
• Biswal AK, Hariprasad P, Saha S. Efficient and prolonged antibacterial activity from porous PLGA microparticles and their application in food preservation. Mater Sci Eng C. 2020;108:110496. doi: 10.1016/j.msec.2019.110496
   PubMed Web of Science ®Google Scholar
• Cocks E, Somavarapu S, Alpar O, et al. Influence of suspension stabilisers on the delivery of protein-loaded porous poly (dl-lactide-co-glycolide)(PLGA) microparticles via pressurised metered dose inhaler (pMDI). Pharm Res. 2014;31(8):2000–2009. doi: 10.1007/s11095-014-1302-x
   PubMed Web of Science ®Google Scholar
• Jiménez A, Peltzer M, Ruseckaite R, et al. Poly(lactic acid) science and technology. Royal Society of Chemistry: 2014. doi: 10.1039/9781782624806
   Google Scholar
• Alkilany AM, Rachid O, Alkawareek MY, et al. PLGA-Gold nanocomposite: preparation and biomedical applications. Pharmaceutics. 2022;14(3):660. doi: 10.3390/pharmaceutics14030660
   PubMed Web of Science ®Google Scholar
• Vlachopoulos A, Karlioti G, Balla E, et al. Poly (Lactic Acid)-based microparticles for drug delivery applications: an overview of recent advances. Pharmaceutics. 2022;14(2):359. doi: 10.3390/pharmaceutics14020359
   PubMed Web of Science ®Google Scholar
• Sheffey VV, Siew EB, Tanner EEL, et al. PLGA’s plight and the role of stealth surface modification strategies in its use for intravenous particulate drug delivery. Adv Healthcare Mater. 2022;11(8):2101536. doi: 10.1002/adhm.202101536
   Web of Science ®Google Scholar
• Vrignaud S, Benoit J-P, Saulnier P. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials. 2011;32(33):8593–8604. doi: 10.1016/j.biomaterials.2011.07.057
   PubMed Web of Science ®Google Scholar
• Chatterjee M, Chanda N. Formulation of PLGA nano-carrier: specialized modification for cancer therapeutic applications. Mater Adv. 2022;3(2):837–858. doi: 10.1039/D1MA00600B
   Google Scholar
• Hasan AS, Socha M, Lamprecht A, et al. Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int J Pharmaceut. 2007;344(1–2):53–61. doi: 10.1016/j.ijpharm.2007.05.066
   PubMed Web of Science ®Google Scholar
• Al-Nemrawi NK, Altawabeyeh RM, Darweesh RS. Preparation and characterization of Docetaxel-PLGA nanoparticles coated with folic acid-chitosan conjugate for cancer treatment. J Pharmaceut sci. 2022;111(2):485–494. doi: 10.1016/j.xphs.2021.10.034
   PubMed Web of Science ®Google Scholar
• Albertsson A-C, Varma IK. Recent developments in ring opening polymerization of lactones for biomedical applications. Biomacromolecules. 2003;4(6):1466–1486. doi: 10.1021/bm034247a
   PubMed Web of Science ®Google Scholar
• Fuoco T, Pappalardo D. Aluminum alkyl complexes bearing salicylaldiminato ligands: versatile initiators in the ring-opening polymerization of cyclic esters. Catalysts. 2017;7(12):64. doi: 10.3390/catal7020064
   Google Scholar
• Jérôme C, Lecomte P. Recent advances in the synthesis of aliphatic polyesters by ring-opening polymerization. Adv Drug Delivery Rev. 2008;60(9):1056–1076. doi: 10.1016/j.addr.2008.02.008
   PubMed Web of Science ®Google Scholar
• Iqbal M, Zafar N, Fessi H, et al. Double emulsion solvent evaporation techniques used for drug encapsulation. Int J Pharmaceut. 2015;496(2):173–190. doi: 10.1016/j.ijpharm.2015.10.057
   PubMed Web of Science ®Google Scholar
• Molavi F, Barzegar-Jalali M, Hamishehkar H. Polyester based polymeric nano and microparticles for pharmaceutical purposes: a review on formulation approaches. J Controlled Release. 2020;320:265–282. doi: 10.1016/j.jconrel.2020.01.028
   PubMed Web of Science ®Google Scholar
• Tasci ME, Dede B, Tabak E, et al. Production, optimization and characterization of polylactic acid microparticles using electrospray with porous structure. Appl Sci. 2021;11(11):5090. doi: 10.3390/app11115090
   Google Scholar
• Morais AÍS, Vieira EG, Afewerki S, et al. Fabrication of polymeric microparticles by electrospray: the impact of experimental parameters. JFB. 2020;11(1):4. doi: 10.3390/jfb11010004
   Google Scholar
• Almoustafa HA, Alshawsh MA, Chik Z. Technical aspects of preparing PEG-PLGA nanoparticles as carrier for chemotherapeutic‎ agents by nanoprecipitation method. Int J Pharmaceut. 2017;533(1):275–284. doi: 10.1016/j.ijpharm.2017.09.054
   PubMed Web of Science ®Google Scholar
• Rivas CJM, Tarhini M, Badri W, et al. Nanoprecipitation process: from encapsulation to drug delivery. Int J Pharmaceut. 2017;532(1):66–81. doi: 10.1016/j.ijpharm.2017.08.064
   PubMed Web of Science ®Google Scholar
• Tabatabaei Mirakabad FS, Nejati-Koshki K, Akbarzadeh A, et al. PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev. 2014;15(2):517–535. doi: 10.7314/APJCP.2014.15.2.517
   PubMedGoogle Scholar
• Mir M, Ahmed N, Ur Rehman A. Recent applications of PLGA based nanostructures in drug delivery. Colloids Surf B Biointerfaces. 2017;159:217–231. doi: 10.1016/j.colsurfb.2017.07.038
   PubMed Web of Science ®Google Scholar
• Giorello A, Nicastro A, Berli CLA. Microfluidic platforms for the production of nanoparticles at flow rates larger than one liter per hour. Adv Mater Technol. 2022;7(9):2101588. doi: 10.1002/admt.202101588
   Web of Science ®Google Scholar
• Hwang J, Mros S, Gamble AB, et al. Improving antibacterial activity of a HtrA Protease inhibitor JO146 against Helicobacter pylori: a novel approach using microfluidics-engineered PLGA nanoparticles. Pharmaceutics. 2022;14(2):348. doi: 10.3390/pharmaceutics14020348
   PubMed Web of Science ®Google Scholar
• Shan X, Gong X, Li J, et al. Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharm Sin B. 2022;12(7):3028–3048. doi: 10.1016/j.apsb.2022.02.025
   PubMed Web of Science ®Google Scholar
• Guan W, Ma Y, Ding S, et al. The technology for improving stability of nanosuspensions in drug delivery. J Nanopart Res. 2022;24(1):1–38. doi: 10.1007/s11051-022-05403-9
   Web of Science ®Google Scholar
• Smirnova VV, Chausov DN, Serov DA, et al. A novel biodegradable composite polymer material based on PLGA and silver oxide nanoparticles with unique physicochemical properties and biocompatibility with mammalian cells. Materials. 2021;14(22):6915. doi: 10.3390/ma14226915
   PubMed Web of Science ®Google Scholar
• Wan B, Andhariya JV, Bao Q, et al. Effect of polymer source on in vitro drug release from PLGA microspheres. Int J Pharmaceut. 2021;607:120907. doi: 10.1016/j.ijpharm.2021.120907
   PubMed Web of Science ®Google Scholar
• Xu Y, Kim C-S, Saylor DM, et al. Polymer degradation and drug delivery in PLGA‐based drug–polymer applications: a review of experiments and theories. J Biomed Mater Res, Part B. 2017;105(6):1692–1716. doi: 10.1002/jbm.b.33648
   PubMed Web of Science ®Google Scholar
• Zhang B, Sai Lung P, Zhao S, et al. Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells. Sci Rep. 2017;7(1):1–8. doi: 10.1038/s41598-017-07588-9
   PubMed Web of Science ®Google Scholar
• Rocha CV, Gonçalves V, da Silva MC, et al. PLGA-Based composites for various biomedical applications. Int J Mol Sci. 2022;23(4):2034. doi: 10.3390/ijms23042034
   PubMed Web of Science ®Google Scholar
• Liu G, McEnnis K. Glass transition temperature of PLGA particles and the influence on drug delivery applications. Polymers. 2022;14(5):993. doi: 10.3390/polym14050993
   PubMed Web of Science ®Google Scholar
• Lim YW, Tan WS, Ho KL, et al. challenges and complications of poly (lactic-co-glycolic acid)-based long-acting drug product development. Pharmaceutics. 2022;14(3):614. doi: 10.3390/pharmaceutics14030614
   PubMed Web of Science ®Google Scholar
• Emami F, Mostafavi Yazdi SJ, Na DH. Poly (lactic acid)/poly (lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery. J Pharm Invest. 2019;49(4):427–442. doi: 10.1007/s40005-019-00443-1
   Google Scholar
• Xu W, Sasaki M, Niidome T. Sirolimus release from biodegradable polymers for coronary stent application: a review. Pharmaceutics. 2022;14(3):492. doi: 10.3390/pharmaceutics14030492
   PubMed Web of Science ®Google Scholar
• Unagolla JM, Jayasuriya AC. Drug transport mechanisms and in vitro release kinetics of vancomycin encapsulated chitosan-alginate polyelectrolyte microparticles as a controlled drug delivery system. Eur J Pharmaceut Sci. 2018;114:199–209. doi: 10.1016/j.ejps.2017.12.012
   PubMed Web of Science ®Google Scholar
• El-Hammadi MM, Arias JL. Recent advances in the surface functionalization of PLGA-Based nanomedicines. Nanomaterials. 2022;12(3):354. doi: 10.3390/nano12030354
   Web of Science ®Google Scholar
• Bikiaris R, Christodoulou E, Kostoglou M, et al. Paliperidone palmitate depot microspheres based on biocompatible poly (alkylene succinate) polyesters as long-acting injectable formulations. J Drug Delivery Sci Technol. 2022;68:103056. doi: 10.1016/j.jddst.2021.103056
   Web of Science ®Google Scholar
• Doty AC, Weinstein DG, Hirota K, et al. Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres. JControlled Release. 2017;256:19–25. doi: 10.1016/j.jconrel.2017.03.031
   PubMed Web of Science ®Google Scholar
• Von Burkersroda F, Schedl L, Göpferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials. 2002;23(21):4221–4231. doi: 10.1016/S0142-9612(02)00170-9
   PubMed Web of Science ®Google Scholar
• Bassand C, Verin J, Lamatsch M, et al. How agarose gels surrounding PLGA implants limit swelling and slow down drug release. JControlled Release. 2022;343:255–266. doi: 10.1016/j.jconrel.2022.01.028
   PubMed Web of Science ®Google Scholar
• Rapier CE, Shea KJ, Lee AP. Investigating PLGA microparticle swelling behavior reveals an interplay of expansive intermolecular forces. Sci Rep. 2021;11(1):1–12. doi: 10.1038/s41598-021-93785-6
   PubMed Web of Science ®Google Scholar
• Dai J, Tan X, Liang M, et al. Fabrication of porous crystalline PLGA-PEG induced by swelling during the recrystallization annealing process. ACS Biomater Sci Eng. 2021;7(12):5524–5531. doi: 10.1021/acsbiomaterials.1c01187
   PubMed Web of Science ®Google Scholar
• Wang C-PJ, Byun MJ, Kim S-N, et al. Biomaterials as therapeutic drug carriers for inflammatory bowel disease treatment. JControlled Release. 2022;345:1–19. doi: 10.1016/j.jconrel.2022.02.028
   PubMed Web of Science ®Google Scholar
• Sahu R, Dixit S, Verma R, et al. Encapsulation of recombinant MOMP in extended-releasing PLGA 85: 15 nanoparticles confer protective immunity against a Chlamydia muridarum genital challenge and re-challenge. Front Immunol. 2021;12:1197. doi: 10.3389/fimmu.2021.660932
   Web of Science ®Google Scholar
• Chachlioutaki K, Karavasili C, Adamoudi E, et al. Silk sericin/PLGA electrospun scaffolds with anti-inflammatory drug-eluting properties for periodontal tissue engineering. Mater Sci Eng C. 2022;133:112723. doi: 10.1016/j.msec.2022.112723
   Google Scholar
• Huang S-J, Wang T-H, Chou Y-H, et al. Hybrid PEGylated chitosan/PLGA nanoparticles designed as Ph-responsive vehicles to promote intracellular drug delivery and cancer chemotherapy. Int j biol macromol. 2022;210:565–578. doi: 10.1016/j.ijbiomac.2022.04.209
   PubMed Web of Science ®Google Scholar
• Pang H, Huang X, Xu ZP, et al. Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes. Drug Discovery Today. 2022;28(1):103393. doi: 10.1016/j.drudis.2022.103393
   PubMed Web of Science ®Google Scholar
• Agnihotri TG, Jadhav GS, Sahu B, et al. Recent trends of bioconjugated nanomedicines through nose-to-brain delivery for neurological disorders. Drug Deliv Transl Res. 2022;12(12):3104–3120. doi: 10.1007/s13346-022-01173-y
   PubMed Web of Science ®Google Scholar
• Shapiro RL, DeLong K, Zulfiqar F, et al. In vitro and ex vivo models for evaluating vaginal drug delivery systems. Adv Drug Delivery Rev. 2022;191:114543. doi: 10.1016/j.addr.2022.114543
   PubMed Web of Science ®Google Scholar
• Perinelli DR, Cespi M, Bonacucina G, et al. Pegylated polylactide (PLA) and poly (lactic-co-glycolic acid)(PLGA) copolymers for the design of drug delivery systems. J Pharm Invest. 2019;49(4):443–458. doi: 10.1007/s40005-019-00442-2
   Google Scholar
• Mohammadinejad R, Dehshahri A, Sagar Madamsetty V, et al. In vivo gene delivery mediated by non-viral vectors for cancer therapy. JControlled Release. 2020;325:249–275. doi: 10.1016/j.jconrel.2020.06.038
   PubMed Web of Science ®Google Scholar
• Mukherjee A, et al., Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Nanomed J, 2019. 14: p. 1937.
   PubMed Web of Science ®Google Scholar
• Maghrebi S, Prestidge CA, Joyce P. An update on polymer-lipid hybrid systems for improving oral drug delivery. Expert Opin Drug Delivery. 2019;16(5):507–524. doi: 10.1080/17425247.2019.1605353
   PubMed Web of Science ®Google Scholar
• Pagels RF, Prud’homme RK. Polymeric nanoparticles and microparticles for the delivery of peptides, biologics, and soluble therapeutics. J Controlled Release. 2015;219:519–535. doi: 10.1016/j.jconrel.2015.09.001
   PubMed Web of Science ®Google Scholar
• Buzmakov AV, Dunaev A, Krivonosov Y, et al. Wide-ranging multitool study of structure and porosity of PLGA scaffolds for tissue engineering. Polymers. 2021;13(7):1021. doi: 10.3390/polym13071021
   PubMed Web of Science ®Google Scholar
• Ragelle H, Danhier F, Préat V, et al. Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures. Expert Opin Drug Delivery. 2017;14(7):851–864. doi: 10.1080/17425247.2016.1244187
   PubMed Web of Science ®Google Scholar
• Payen VL, Brisson L, Dewhirst MW, et al. Common responses of tumors and wounds to hypoxia. Cancer J. 2015;21(2):75–87. doi: 10.1097/PPO.0000000000000098
   PubMed Web of Science ®Google Scholar
• Sun S, Li H, Chen J, et al. Lactic acid: no longer an inert and end-product of glycolysis. Physiology. 2017;32(6):453–463. doi: 10.1152/physiol.00016.2017
   PubMed Web of Science ®Google Scholar
• Curran CS, Kopp JB. Aryl hydrocarbon receptor mechanisms affecting chronic kidney disease. Front Pharmacol. 2022;13:782199–782199. doi: 10.3389/fphar.2022.782199
   PubMed Web of Science ®Google Scholar
• Chen S, Zhou L, Sun J, et al. The role of camp-PKA pathway in lactate-induced intramuscular triglyceride accumulation and mitochondria content increase in mice. Front Physiol. 2021;12:12. doi: 10.3389/fphys.2021.709135
   Web of Science ®Google Scholar
• Luo Y, Li L, Chen X, et al. Effects of lactate in immunosuppression and inflammation: progress and prospects. Int Rev Immunol. 2022;41(1):19–29. doi: 10.1080/08830185.2021.1974856
   PubMed Web of Science ®Google Scholar
• Certo M, Tsai C-H, Pucino V, et al. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol. 2021;21(3):151–161. doi: 10.1038/s41577-020-0406-2
   PubMed Web of Science ®Google Scholar
• Holzer P. Acid-sensitive ion channels and receptors. Sensory nerves. 2009;283–332.
   Google Scholar
• Weder B, Schefer F, van Haaften WT, et al. New therapeutic approach for intestinal fibrosis through inhibition of ph-sensing receptor GPR4. Inflamm Bowel Dis. 2022;28(1):109–125. doi: 10.1093/ibd/izab140
   PubMed Web of Science ®Google Scholar
• Li Z, et al. Normalization of tumor microvasculature basing on targeting and modulation of tumor microenvironment. Nanoscale. 2021;13:17254–17271.
   Google Scholar
• Hayes C, Donohoe CL, Davern M, et al. The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment. Cancer Lett. 2021;500:75–86. doi: 10.1016/j.canlet.2020.12.021
   PubMed Web of Science ®Google Scholar
• Narmani A, Kamali M, Amini B, et al. Targeting delivery of oxaliplatin with smart PEG-modified PAMAM G4 to colorectal cell line: in vitro studies. Process Biochem. 2018;69:178–187. doi: 10.1016/j.procbio.2018.01.014
   Web of Science ®Google Scholar
• Liu Y, Workalemahu B, Jiang X. The effects of physicochemical properties of nanomaterials on their cellular uptake in vitro and in vivo. Small. 2017;13(43):1701815. doi: 10.1002/smll.201701815
   Web of Science ®Google Scholar
• Amini A, Kamali M, Amini B, et al. Bio-barcode technology for detection of Staphylococcus aureus protein a based on gold and iron nanoparticles. Int j biol macromol. 2019;124:1256–1263. doi: 10.1016/j.ijbiomac.2018.11.123
   PubMed Web of Science ®Google Scholar
• Srinivasarao M, Galliford CV, Low PS. Principles in the design of ligand-targeted cancer therapeutics and imaging agents. Nat Rev Drug Discov. 2015;14(3):203–219. doi: 10.1038/nrd4519.
   PubMed Web of Science ®Google Scholar
• Faramarzi N, Mohammadnejad J, Jafary H, et al. Synthesis and in vitro evaluation of tamoxifen-loaded gelatin as effective nanocomplex in drug delivery systems. Int J Nanosci. 2020;19(5):2050002. doi: 10.1142/S0219581X20500027
   Web of Science ®Google Scholar
• Abd Ellah NH, Abouelmagd SA. Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges. Expert Opin Drug Delivery. 2017;14(2):201–214. doi: 10.1080/17425247.2016.1213238
   PubMed Web of Science ®Google Scholar
• Narmani A, Rezvani M, Farhood B, et al. Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems. Drug Dev Res. 2019;80(4):404–424. doi: 10.1002/ddr.21545
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Mazumder P, Joshi M, et al. Biomedical application, drug delivery and metabolic pathway of antiviral nanotherapeutics for combating viral pandemic: a review. Environ Res. 2020;191:110119. doi: 10.1016/j.envres.2020.110119
   PubMed Web of Science ®Google Scholar
• Moutabian H, et al. The cardioprotective effects of nano‐curcumin against doxorubicin‐induced cardiotoxicity: a systematic review. BioFactors. 2022;48:597–610.
   Google Scholar
• Bae YH, Park K. Advanced drug delivery 2020 and beyond: perspectives on the future. Adv Drug Delivery Rev. 2020;158:4–16. doi: 10.1016/j.addr.2020.06.018
   PubMed Web of Science ®Google Scholar
• Fotouhi P, Sohrabi S, Nosrati N, et al. Surface modified and rituximab functionalized PAMAM G4 nanoparticle for targeted imatinib delivery to leukemia cells: in vitro studies. Process Biochem. 2021;111:221–229. doi: 10.1016/j.procbio.2021.09.006
   Web of Science ®Google Scholar
• Zhao X, Si J, Huang D, et al. Application of star poly (ethylene glycol) derivatives in drug delivery and controlled release. JControlled Release. 2020;323:565–577. doi: 10.1016/j.jconrel.2020.04.039
   PubMed Web of Science ®Google Scholar
• Wu P, Zhou Q, Zhu H, et al. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. BMC Cancer. 2020;20(1):1–10. doi: 10.1186/s12885-020-06803-7
   Web of Science ®Google Scholar
• Klippstein R, Wang JT-W, El-Gogary RI, et al. Passively targeted curcumin‐loaded pegylated PLGA nanocapsules for colon cancer therapy in vivo. Small. 2015;11(36):4704–4722. doi: 10.1002/smll.201403799
   PubMed Web of Science ®Google Scholar
• Zi Y, Yang K, He J, et al. Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms. Adv Drug Delivery Rev. 2022;188:114449. doi: 10.1016/j.addr.2022.114449
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37. doi: 10.1038/nrc.2016.108
   PubMed Web of Science ®Google Scholar
• Danhier F. To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine? JControlled Release. 2016;244:108–121. doi: 10.1016/j.jconrel.2016.11.015
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang K, Zheng Y, et al. Co-delivery of salinomycin and curcumin for cancer stem cell treatment by inhibition of cell proliferation, cell cycle arrest, and epithelial–mesenchymal transition. Front Chem. 2021;8:1149. doi: 10.3389/fchem.2020.601649
   Web of Science ®Google Scholar
• In’t Veld RVH, Ritsma L, Kleinovink JW, et al. Photodynamic cancer therapy enhances accumulation of nanoparticles in tumor-associated myeloid cells. JControlled Release. 2020;320:19–31. doi: 10.1016/j.jconrel.2019.12.052
   PubMed Web of Science ®Google Scholar
• Alvear-Jiménez A, Zabala Gutierrez I, Shen Y, et al. Electrospraying as a technique for the controlled synthesis of biocompatible PLGA@ Ag2S and PLGA@ Ag2S@ SPION nanocarriers with drug release capability. Pharmaceutics. 2022;14(1):214. doi: 10.3390/pharmaceutics14010214
   PubMed Web of Science ®Google Scholar
• Kim H-Y, Li R, Ng TSC, et al. Quantitative imaging of tumor-associated macrophages and their response to therapy using 64Cu-labeled macrin. ACS Nano. 2018;12(12):12015–12029. doi: 10.1021/acsnano.8b04338
   PubMed Web of Science ®Google Scholar
• Xiao L, Huang Y, Yang Y, et al. Biomimetic cytomembrane nanovaccines prevent breast cancer development in the long term. Nanoscale. 2021;13(6):3594–3601. doi: 10.1039/D0NR08978H
   PubMed Web of Science ®Google Scholar
• Liu L, et al. A biomimetic polymer magnetic nanocarrier polarizing tumor‐associated macrophages for potentiating immunotherapy. Small. 2020;16(38):2003543. doi: 10.1002/smll.202003543
   Web of Science ®Google Scholar
• Elbassiouni FE, El-Kholy WM, Elhabibi E-SM, et al. Comparative study between curcumin and nanocurcumin loaded PLGA on colon carcinogenesis induced mice. Nanomaterials. 2022;12(3):324. doi: 10.3390/nano12030324
   Web of Science ®Google Scholar
• Wei B, Pan J, Yuan R, et al. Polarization of tumor-associated macrophages by nanoparticle-loaded Escherichia coli combined with immunogenic cell death for cancer immunotherapy. Nano Lett. 2021;21(10):4231–4240. doi: 10.1021/acs.nanolett.1c00209
   PubMed Web of Science ®Google Scholar
• Deepika MS, Thangam R, Sheena TS, et al. Dual drug loaded PLGA nanospheres for synergistic efficacy in breast cancer therapy. Mater Sci Eng C. 2019;103:109716. doi: 10.1016/j.msec.2019.05.001
   PubMed Web of Science ®Google Scholar
• Guo K, Liu Y, Tang L, et al. Homotypic biomimetic coating synergizes chemo-photothermal combination therapy to treat breast cancer overcoming drug resistance. Chem Eng J. 2022;428:131120. doi: 10.1016/j.cej.2021.131120
   Web of Science ®Google Scholar
• Zumaya ALV, Rimpelová S, Štějdířová M, et al. Antibody conjugated PLGA nanocarriers and superparmagnetic nanoparticles for targeted delivery of Oxaliplatin to cells from colorectal carcinoma. Int J Mol Sci. 2022;23(3):1200. doi: 10.3390/ijms23031200
   PubMed Web of Science ®Google Scholar
• Wang H, Agarwal P, Zhao S, et al. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells. Biomaterials. 2015;72:74–89. doi: 10.1016/j.biomaterials.2015.08.048
   PubMed Web of Science ®Google Scholar
• Gao J, Liu J, Xie F, et al. CO-delivery of docetaxel and salinomycin to target both breast cancer cells and stem cells by PLGA/TPGS nanoparticles. Int J Nanomed. 2019;14:9199. doi: 10.2147/IJN.S230376
   PubMed Web of Science ®Google Scholar
• Wang L, Hu Y, Hao Y, et al. Tumor-targeting core-shell structured nanoparticles for drug procedural controlled release and cancer sonodynamic combined therapy. JControlled Release. 2018;286:74–84.
   PubMed Web of Science ®Google Scholar
• Alanazi JS, Alqahtani FY, Aleanizy FS, et al. MicroRNA-539-5p-loaded PLGA nanoparticles grafted with iRGD as a targeting treatment for choroidal Neovascularization. Pharmaceutics. 2022;14(2):243. doi: 10.3390/pharmaceutics14020243
   PubMed Web of Science ®Google Scholar
• Paul B, Gaonkar RH, Dutta D, et al. Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma. Mater Sci Eng C. 2022;134:112714. doi: 10.1016/j.msec.2022.112714
   Google Scholar
• Zhang Y, Wang Y, Xin Q, et al. Zwitterionic choline phosphate conjugated folate-poly (ethylene glycol): a general decoration of erythrocyte membrane-coated nanoparticles for enhanced tumor-targeting drug delivery. J Mat Chem B. 2022;10(14):2497–2503. doi: 10.1039/D1TB02493K
   PubMed Web of Science ®Google Scholar
• Helmy SA, El-Mofty S, El Gayar AM, et al. Novel doxorubicin/folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: in-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment. Biomed Pharmacother. 2022;145:112376. doi: 10.1016/j.biopha.2021.112376
   PubMed Web of Science ®Google Scholar
• Hao Y, Zhang B, Zheng C, et al. The tumor-targeting core–shell structured DTX-loaded PLGA@ Au nanoparticles for chemo-photothermal therapy and X-ray imaging. JControlled Release. 2015;220:545–555. doi: 10.1016/j.jconrel.2015.11.016
   PubMed Web of Science ®Google Scholar
• Sweeney EE, Balakrishnan PB, Powell AB, et al. PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function. Nano Res. 2020;13(3):736–744. doi: 10.1007/s12274-020-2684-1
   PubMed Web of Science ®Google Scholar
• Li T, Yang Y, Jing W, et al. Melanin-gelatin nanoparticles with both EPR effect and renal clearance for PA/MRI dual-modal imaging of tumors. Mater Sci Eng C. 2022;134:112718. doi: 10.1016/j.msec.2022.112718
   Google Scholar
• Rezvani M, Mohammadnejad J, Narmani A, et al. Synthesis and in vitro study of modified chitosan-polycaprolactam nanocomplex as delivery system. Int j biol macromol. 2018;113:1287–1293. doi: 10.1016/j.ijbiomac.2018.02.141
   PubMed Web of Science ®Google Scholar
• Stipa P, Marano S, Galeazzi R, et al. Prediction of drug-carrier interactions of PLA and PLGA drug-loaded nanoparticles by molecular dynamics simulations. Eur Polym J. 2021;147:110292. doi: 10.1016/j.eurpolymj.2021.110292
   Web of Science ®Google Scholar
• Khakinahad Y, Sohrabi S, Razi S, et al. Margetuximab conjugated-PEG-PAMAM G4 nano-complex: a smart nano-device for suppression of breast cancer. Biomed Eng Lett. 2022;12(3):317–329. doi: 10.1007/s13534-022-00225-z
   PubMed Web of Science ®Google Scholar
• Dana P, Bunthot S, Suktham K, et al. Active targeting liposome-PLGA composite for cisplatin delivery against cervical cancer. Colloids Surf B Biointerfaces. 2020;196:111270. doi: 10.1016/j.colsurfb.2020.111270
   PubMed Web of Science ®Google Scholar
• Zeb A, Gul M, Nguyen TTL, et al. Controlled release and targeted drug delivery with poly (lactic-co-glycolic acid) nanoparticles: reviewing two decades of research. J Pharm Invest. 2022;52(6):683–724. doi: 10.1007/s40005-022-00584-w
   Web of Science ®Google Scholar
• Scheeren LE, Nogueira-Librelotto DR, Mathes D, et al. Multifunctional PLGA nanoparticles combining transferrin-targetability and Ph-stimuli sensitivity enhanced doxorubicin intracellular delivery and in vitro antineoplastic activity in MDR tumor cells. Toxicol In Vitro. 2021;75:105192. doi: 10.1016/j.tiv.2021.105192
   PubMed Web of Science ®Google Scholar
• Arslan FB, Öztürk K, Tavukçuoğlu E, et al. A novel combination for the treatment of small cell lung cancer: active targeted irinotecan and stattic co-loaded PLGA nanoparticles. Int J Pharmaceut. 2023;632:122573. doi: 10.1016/j.ijpharm.2022.122573
   PubMed Web of Science ®Google Scholar
• Yang C, He B, Dai W, et al. The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems. Acta Pharm Sin B. 2021;11(4):961–977. doi: 10.1016/j.apsb.2020.11.020
   PubMed Web of Science ®Google Scholar
• Vasey CE, Cavanagh RJ, Taresco V, et al. Polymer pro-drug nanoparticles for sustained release of cytotoxic drugs evaluated in patient-derived glioblastoma cell lines and in situ gelling formulations. Pharmaceutics. 2021;13(2):208. doi: 10.3390/pharmaceutics13020208
   PubMed Web of Science ®Google Scholar
• Xu E, Saltzman WM, Piotrowski-Daspit AS. Escaping the endosome: assessing cellular trafficking mechanisms of non-viral vehicles. JControlled Release. 2021;335:465–480. doi: 10.1016/j.jconrel.2021.05.038
   PubMed Web of Science ®Google Scholar
• Zhou S, Wu J, Huang X, et al. Cellular uptake of a cationic amphiphilic fluorophore in the form of assemblies via Clathrin-dependent endocytosis. Mater Design. 2021;200:109464. doi: 10.1016/j.matdes.2021.109464
   Web of Science ®Google Scholar
• Wright L, Joyce P, Barnes TJ, et al. A comparison of chitosan, mesoporous silica and poly (lactic-co-glycolic) acid nanocarriers for optimising intestinal uptake of oral protein therapeutics. J Pharmaceut sci. 2021;110(1):217–227. doi: 10.1016/j.xphs.2020.09.026
   PubMed Web of Science ®Google Scholar
• Zhi K, Raji B, Nookala AR, et al. PLGA nanoparticle-based formulations to cross the blood–brain barrier for drug delivery: from R&D to cGMP. Pharmaceutics. 2021;13(4):500. doi: 10.3390/pharmaceutics13040500
   PubMed Web of Science ®Google Scholar
• Veeran MG, Thomas RR, Ramakrishnan R, et al. QuaLity-by-design approach for optimization and processing of PLGA polymer film by hot melt extrusion. J Pharm Innov. 2022;17(4):1282–1294. doi: 10.1007/s12247-021-09600-2
   Web of Science ®Google Scholar
• Malinovskaya Y, Melnikov P, Baklaushev V, et al. Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells. Int J Pharmaceut. 2017;524(1–2):77–90. doi: 10.1016/j.ijpharm.2017.03.049
   PubMed Web of Science ®Google Scholar
• Operti MC, Bernhardt A, Sincari V, et al. IndustrIal scale manufacturing and downstream processing of PLGA-Based nanomedicines suitable for fully continuous operation. Pharmaceutics. 2022;14(2):276. doi: 10.3390/pharmaceutics14020276
   PubMed Web of Science ®Google Scholar
• Wasalathanthri DP, Feroz H, Puri N, et al. Real‐time monitoring of quality attributes by in‐line fourier transform infrared spectroscopic sensors at ultrafiltration and diafiltration of bioprocess. Biotechnol Bioeng. 2020;117(12):3766–3774. doi: 10.1002/bit.27532
   PubMed Web of Science ®Google Scholar
• Park K, Skidmore S, Hadar J, et al. Injectable, long-acting PLGA formulations: analyzing PLGA and understanding microparticle formation. JControlled Release. 2019;304:125–134. doi: 10.1016/j.jconrel.2019.05.003
   PubMed Web of Science ®Google Scholar
• Lee BK, Yun Y, Park K. PLA micro- and nano-particles. Adv Drug Delivery Rev. 2016;107:176–191. doi: 10.1016/j.addr.2016.05.020
   PubMed Web of Science ®Google Scholar
• Pardeshi SR, Nikam A, Chandak P, et al. Recent advances in PLGA based nanocarriers for drug delivery system: a state of the art review. Int J Polym Mater Polym Biomater. 2021;72(1):49–78. doi: 10.1080/00914037.2021.1985495
   Web of Science ®Google Scholar
• Vickers NJ. Animal communication: when i’m calling you, will you answer too? Curr Biol. 2017;27(14):R713–R715. doi: 10.1016/j.cub.2017.05.064
   PubMed Web of Science ®Google Scholar
• Chen H, Li F, Yao Y, et al. Redox dual-responsive and o2‑evolving theranostic nanosystem for highly selective chemotherapy against hypoxic tumors. Theranostics. 2019;9(1):90. doi: 10.7150/thno.30259
   PubMed Web of Science ®Google Scholar
• Yao W, Yao J, Qian F, et al. Paclitaxel-loaded and folic acid-modified PLGA nanomedicine with glutathione response for the treatment of lung cancer. ABBS. 2021;53(8):1027–1036. doi: 10.1093/abbs/gmab073
   Google Scholar
• Li X, Luo L, Jiang M, et al. Cocktail strategy for ‘cold’tumors therapy via active recruitment of CD8+ T cells and enhancing their function. JControlled Release. 2021;334:413–426. doi: 10.1016/j.jconrel.2021.05.002
   PubMed Web of Science ®Google Scholar
• Cappellano G, Comi C, Chiocchetti A, et al. Exploiting PLGA-based biocompatible nanoparticles for next-generation tolerogenic vaccines against autoimmune disease. Int J Mol Sci. 2019;20(1):204. doi: 10.3390/ijms20010204
   PubMed Web of Science ®Google Scholar
• Cayero-Otero M, Gomes MJ, Martins C, et al. In vivo biodistribution of venlafaxine-PLGA nanoparticles for brain delivery: plain vs. functionalized nanoparticles. Expert Opin Drug Delivery. 2019;16(12):1413–1427. doi: 10.1080/17425247.2019.1690452
   PubMed Web of Science ®Google Scholar